Adult Giant Cell Glioblastoma Completed Phase 1 Trials for Arsenic trioxide (DB01169)

IndicationStatusPhase
DBCOND0028733 (Adult Giant Cell Glioblastoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00045565Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaTreatment